Hypothyroidism may exacerbate valproate-related hyperammonemic delirium
نویسندگان
چکیده
A 41-year-old woman was diagnosed with bipolar disorder at 31. After a thyroidectomy at 33 years old, she was found to have subclinical hypothyroidism: the thyroid-stimulating hormone (TSH) was 6.196 uIU/ml (reference range: 0.34-5.60) and free thyroxine (FT4) was 0.46 ng/dl (reference range: 0.54-1.40). No intervention was given due to her refusal. She started to participate in the day-care unit at 36 years old and received 1500mg/day of sodium valproate (1000 mg at 9 AM and 500mg at noon). Her VPA serum levels at 9 AM before taking her medication were between 44.3-54.8 ug/ml (reference range: 50-100), and her ammonia was at 60 ug/dl (reference range: < 70). With the medication she had both stable physical and psychiatric conditions. One day, when she was 37, she was going about her routine life without any clinical symptoms after taking the 500mg of VPA at noon. Then, she suddenly experienced deteriorated consciousness at 2 PM and, consequently, delirium at 4 PM. Her ammonia soared to 700 ug/dl, and her VPA level was 130.3 ug/ml. TSH concentration increased to 8.867 uIU/ml, while FT4 remained similar (0.47 ng/dl). Other lab data showed negative findings. She remained delirious, her ammonia decreased to 352 ug/dl at 6PM with supportive care at the Emergency Department. She was hospitalized. Valproate was discontinued. The next morning, her consciousness improved partially, ammonia declined to 86 ug/ dl and VPA fell to 73.9 ug/ml at 9AM. 400 mg/day of Carbamazepine was given to the patient to treat her bipolar disorder, reaching a level of 6.8 ug/ml in the patient’s blood after one week. Meanwhile, her ammonia descended to 45 ug/dl. She was discharged one month later. With thyroxine supplement during the outpatient follow-up, her FT4 and TSH
منابع مشابه
Hypothyroidism exacerbating valproate induced hyperammonemic delirium, an unknown clinical concern: Short communication
From the literature reviews, valproic acid (VPA) induced hyperammonemia is a commonly adverse event and usually asymptomatic. VPA is a well-tolerated and an effective agent for the treatment of epilepsy, bipolar disorder, schizoaffective disorder, off-lable use for the impulsive control problems and etc. However, several case reports have indicated that VPA may induce serious symptomatic hypera...
متن کاملNon-Hyperammonemic valproate encephalopathy
A 21-year-old male known case of primary hypothyroidism, Seizure disorder sequelae of an old trauma receiving sodium valproate, clobazam and phenobarbitone for control of Generalized tonic clonic seizures reported to neurology OPD with history of altered sensorium and gait unsteadiness for 1 week with history of hike in valproate dose 2 weeks before. On examination he was drowsy. Neurological e...
متن کاملValproate-induced hyperammonemic encephalopathy with normal liver function.
Hyperammonemic encephalopathy with normal liver function is an uncommon serious adverse effect of valproate therapy. We retrospectively analyzed the case records of 5 patients of epilepsy on valproate with hyperammonemic encephalopathy. Of the 5 patients, 3 were on monotherapy. The mean valproate dose was 1250 mg/day and the duration of therapy ranged between 4 and 90 days. Alteration in the se...
متن کاملA Case of Valproate Induced Hyperammonemic Encephalopathy
A 36-years-old man on phenytoin, levetiracetam, and sodium valproate presented with acute confusion. Routine investigations including serum valproate and phenytoin concentration were normal. His serum ammonia concentration was raised. His valproate was held and 2 days later he recovered with concordant normalisation of serum ammonia concentration. Urea acid cycle disorder was ruled out, and a d...
متن کاملValproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.
The anticonvulsant agent valproate (VPA) may cause hyperammonemic encephalopathy. Magnetic resonance imaging (MRI) and proton MR spectroscopic (MRS) findings in a patient with VPA-induced hyperammonemic encephalopathy are described. MRI showed a metabolic-toxic lesion pattern with bilateral T2-hyperintense lesions in the cerebellar white matter and in the globus pallidus. MR spectroscopic findi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 6 شماره
صفحات -
تاریخ انتشار 2016